YUPELRI provides Chronic Obstructive Pulmonary Disease (COPD) patients in the U.S. with access to a nebulized, long-acting muscarinic antagonist (LAMA) therapy that offers consistent lung function improvement with the convenience of oncedaily dosing delivered through any standard jet nebulizer.